|
1
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ou SH, Zell JA, Ziogas A and Anton-Culver
H: Epidemiology of nasopharyngeal carcinoma in the United States:
Improved survival of Chinese patients within the keratinizing
squamous cell carcinoma histology. Ann Oncol. 18:29–35. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jia WH, Luo XY, Feng BJ, Ruan HL, Bei JX,
Liu WS, Qin HD, Feng QS, Chen LZ, Yao SY and Zeng YX: Traditional
Cantonese diet and nasopharyngeal carcinoma risk: A large-scale
case-control study in Guangdong, China. BMC Cancer. 10:4462010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cao SM, Simons MJ and Qian CN: The
prevalence and prevention of nasopharyngeal carcinoma in China.
Chin J Cancer. 30:114–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sze H, Blanchard P, Ng WT, Pignon JP and
Lee AW: Chemotherapy for nasopharyngeal carcinoma-current
recommendation and controversies. Hematol Oncol Clin North Am.
29:1107–1122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gong C, Nie Y, Qu S, Liao JY, Cui X, Yao
H, Zeng Y, Su F, Song E and Liu Q: miR-21 induces myofbroblast
differentiation and promotes the malignant progression of breast
phyllodes tumors. Cancer Res. 74:4341–4352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Othman N and Nagoor NH: The role of
microRNAs in the regulation of apoptosis in lung cancer and its
application in cancer treatment. Biomed Res Int. 2014:3180302014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lönnroth C, Andersson M, Asting AG,
Nordgren S and Lundholm K: Preoperative low dose NSAID treatment
influences the genes for stemness, growth, invasion and metastasis
in colorectal cancer. Int J Oncol. 45:2208–2220. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu N, Tang LL, Sun Y, Cui RX, Wang HY,
Huang BJ, He QM, Jiang W and Ma J: MiR-29c suppresses invasion and
metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer
Lett. 329:181–188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wong TS, Man OY, Tsang CM, Tsao SW, Tsang
RK, Chan JY, Ho WK, Wei WI and To VS: MicroRNA let-7 suppresses
nasopharyngeal carcinoma cells proliferation through downregulating
c-Myc expression. J Cancer Res Clin Oncol. 137:415–422. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang P, Hong H, Sun X, Jiang H, Ma S,
Zhao S, Zhang M, Wang Z, Jiang C and Liu H: MicroRNA-10b regulates
epithelial-mesenchymal transition by modulating
KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal
carcinoma cells. Am J Cancer Res. 6:141–156. 2016.PubMed/NCBI
|
|
15
|
Zhang H, Cao H, Xu D and Zhu K:
Microrna-92a promotes metastasis of nasopharyngeal carcinoma by
targeting the PTEN/AKT pathway. Onco Targets Ther. 9:3579–3588.
2016.PubMed/NCBI
|
|
16
|
Cai HH, An Y, Chen X, Sun D, Chen T, Peng
Y, Zhu F, Jiang Y and He X: Epigenetic inhibition of miR-663b by
long non-coding RNA HOTAIR promotes pancreatic cancer cell
proliferation via up-regulation of insulin-like growth factor 2.
Oncotarget. 7:86857–86870. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Du M, Shi D, Yuan L, Li P, Chu H, Qin C,
Yin C, Zhang Z and Wang M: Circulating miR-497 and miR-663b in
plasma are potential novel biomarkers for bladder cancer. Sci Rep.
5:104372015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao H, Li M, Li L, Yang X, Lan G and
Zhang Y: MiR-133b is down-regulated inhuman osteosarcomaand
inhibits osteosarcoma cells proliferation, migrationand invasion,
and promotes apoptosis. PLoS One. 8:e835712013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang S, Zhang N, Deng Y, Chen L, Zhang Y,
Zheng Z, Luo W, Lv Z, Li S and Xun T: Increased serum level of
MicroRNA-663 is correlated with poor prognosis of patients with
nasopharyngeal carcinoma. Dis Markers. 2016:76482152016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
He ML, Luo MX, Lin MC and Kung HF:
MicroRNAs: Potential diagnostic markers and therapeutic targets for
EBV-associated nasopharyngeal carcinoina. Biochim Biophys Acta.
1825:1–10. 2012.PubMed/NCBI
|
|
24
|
Tan GJ, Tang XW and Tang FQ: The role of
microRNAs in nasopharyngeal carcinoma. Tumour Biol. 36:69–79. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bruce JP and Liu FF: MicroRNAs in
nasopharyngeal carcinoma. Chin J Cancer. 33:539–544. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia H, Cheung WK, Sze J, Lu G, Jiang S,
Yao H, Bian XW, Poon WS, Kung HF and Lin MC: miR-200a regulates
epithelial-mesenchymal to stem-like transition via ZEB2 and
beta-catenin signaling. J Biol Chem. 285:36995–37004. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF and Li XP: MiR-26a inhibits
cell growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu L, Lu J, Zhang B, Liu X, Wang L, Li SY,
Peng XH, Xu X, Tian WD and Li XP: miR-26a inhibits invasion and
metastasis of nasopharyngeal cancer by targeting EZH2. Oncol Lett.
5:1223–1228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo L, Li N, Lv N and Huang D: SMAD7: A
timer of tumor progression targeting TGF-β signaling. Tumour Bio.
35:8379–8385. 2014. View Article : Google Scholar
|
|
31
|
Zavadil J and Böttinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Muraoka RS, Dumont N, Ritter CA, Dugger
TC, Brantley DM, Chen J, Easterly E, Roebuck LR, Ryan S, Gotwals
PJ, et al: Blockade of TGF-beta inhibits mammary tumor cell
viability, migration, and metastases. J Clin Invest. 109:1551–1559.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iyengar PV and Eichhorn PJ:
(De)-Ubiquitination in the TGF-β pathway. Cancer Res Ther Oncol.
1:1–6. 2013.
|
